ES2098263T3 - 8-alfa-acilamino-ergolinas, su preparacion y su utilizacion como medicamentos. - Google Patents

8-alfa-acilamino-ergolinas, su preparacion y su utilizacion como medicamentos.

Info

Publication number
ES2098263T3
ES2098263T3 ES90906872T ES90906872T ES2098263T3 ES 2098263 T3 ES2098263 T3 ES 2098263T3 ES 90906872 T ES90906872 T ES 90906872T ES 90906872 T ES90906872 T ES 90906872T ES 2098263 T3 ES2098263 T3 ES 2098263T3
Authority
ES
Spain
Prior art keywords
alpha
ergolins
acilamino
medicines
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90906872T
Other languages
English (en)
Inventor
Gerhard Sauer
Thomas Brumby
Helmut Wachtel
Jonathan Turner
Peter Andreas Loschmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Application granted granted Critical
Publication of ES2098263T3 publication Critical patent/ES2098263T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/10—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hetero atoms directly attached in position 8
    • C07D457/12—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

SE DESCRIBEN COMPUESTOS DE LA FORMULA (I) EN LOS QUE R (AL CUADRADO) , R ELEVADO 6 Y R ELEVADO 8 TIENEN LOS SIGNIFICADOS DADOS EN LA DESCRIPCION, SU PREPARACION Y SU USO COMO MEDICAMENTOS.
ES90906872T 1989-05-12 1990-05-10 8-alfa-acilamino-ergolinas, su preparacion y su utilizacion como medicamentos. Expired - Lifetime ES2098263T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3915950A DE3915950A1 (de) 1989-05-12 1989-05-12 8(alpha)-acylamino-ergoline, ihre herstellung und verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
ES2098263T3 true ES2098263T3 (es) 1997-05-01

Family

ID=6380759

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90906872T Expired - Lifetime ES2098263T3 (es) 1989-05-12 1990-05-10 8-alfa-acilamino-ergolinas, su preparacion y su utilizacion como medicamentos.

Country Status (14)

Country Link
US (2) US5212178A (es)
EP (1) EP0427827B1 (es)
JP (1) JPH04500681A (es)
AT (1) ATE147742T1 (es)
CA (1) CA2028832A1 (es)
CZ (2) CZ279080B6 (es)
DD (1) DD294259A5 (es)
DE (2) DE3915950A1 (es)
DK (1) DK0427827T3 (es)
ES (1) ES2098263T3 (es)
HU (1) HU212814B (es)
PT (1) PT94011B (es)
SK (2) SK233190A3 (es)
WO (1) WO1990013550A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6018332A (en) * 1997-11-21 2000-01-25 Ark Interface Ii, Inc. Overscan user interface
US8113807B2 (en) * 2007-08-24 2012-02-14 Timothy Wilkinson Methods and apparatus for fabricating structures
EP2793580A4 (en) * 2011-12-19 2015-05-20 Map Pharmaceuticals Inc NEW DERIVATIVES OF ISO-ERGOLINE
US9657020B2 (en) 2015-01-20 2017-05-23 Xoc Pharmaceuticals, Inc. Ergoline compounds and uses thereof
BR112017015510A2 (pt) 2015-01-20 2018-01-30 Xoc Pharmaceuticals Inc composto de fórmula estrutural (i), método de tratamento e/ou prevenção, método de agonização do receptor d2 em um indivíduo, método de antagonização do receptor d3 em um indivíduo, método de agonização do receptor 5-ht1d em um indivíduo, método de agonização do receptor 5-ht1a em um indivíduo, método de agonização seletiva do receptor 5-ht1d em vez do receptor 5-ht1b em um indivíduo, método de agonização seletiva do re-ceptor 5-ht2c em vez do receptor 5-ht2a ou 5-ht2b em um indivíduo, método de agonização do receptor 5-ht2c em um indivíduo, método de fornecimento de atividade antagonista funcional no receptor 5-ht2b ou receptor 5-ht7, e, método de fornecimento de atividade antagonista funcional nos receptores adrenérgicos em um indivíduo
CA3064274A1 (en) 2017-06-01 2018-12-06 Xoc Pharmaceuticals, Inc. Ergoline derivatives for use in medicine

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2864822A (en) * 1956-10-22 1958-12-16 Lilly Co Eli 9-amino-7-methyl-belta10-ergolene and derivatives thereof
CH615929A5 (en) * 1975-06-02 1980-02-29 Sandoz Ag Process for the preparation of novel ergoline compounds
DE3127845A1 (de) * 1980-07-25 1982-04-22 Sandoz-Patent-GmbH, 7850 Lörrach Ergolinderivate, verfahren zu deren herstellung, diese enthaltende pharmazeutische zusammensetzungen und ihre anwendung bei der therapeutischen behandlung
DE3135305C2 (de) * 1981-09-03 1983-07-21 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur Herstellung von 8-Ergolinyl-harnstoffen
DE3151912A1 (de) * 1981-12-23 1983-06-30 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue ergolin-aminoderivate, verfahren zu ihrer herstellung und deren verwendung als arzneimittel
HU196399B (en) * 1983-02-16 1988-11-28 Sandoz Ag Process for producing ergoline derivatives and pharmaceutical compositions comprising such compounds
DE3309493A1 (de) * 1983-03-14 1984-09-20 Schering AG, 1000 Berlin und 4709 Bergkamen Neue ergolin-derivate, verfahren zu ihrer herstellung sowie verwendung als arzneimittel
CH664568A5 (de) * 1984-01-12 1988-03-15 Sandoz Ag 8-alpha-acylaminoergoline.
DE3587860D1 (de) * 1984-04-09 1994-07-28 Schering Ag 2-substituierte Ergolin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel.
CH666035A5 (de) * 1984-12-24 1988-06-30 Sandoz Ag 8-alpha-acylaminoergolene.
DE3544365A1 (de) * 1984-12-24 1986-07-03 Sandoz-Patent-GmbH, 7850 Lörrach 8(alpha)-acylaminoergoline
DE3528584A1 (de) * 1985-08-06 1987-02-19 Schering Ag Neue 1-alkyl-ergolin-thioharnstoffderivate
NL8700046A (nl) * 1986-01-24 1987-08-17 Sandoz Ag 8 alfa-acylaminoergolinen, werkwijzen voor hun bereiding en farmaceutische preparaten die ze bevatten.
DE3700825A1 (de) * 1986-01-24 1987-07-30 Sandoz Ag 8(alpha)-acylaminoergoline, ihre herstellung und verwendung
DE3620293A1 (de) * 1986-06-16 1987-12-17 Schering Ag 1-und/oder 2-substituierte ergolinderivate
DE3708028A1 (de) * 1987-03-10 1988-09-22 Schering Ag Verfahren zur herstellung von 2,3ss-dihydroergolinen, 2-substituierte 2,3ss-dihydroergoline und ihre verwendung als arzneimittel

Also Published As

Publication number Publication date
CA2028832A1 (en) 1990-11-13
ATE147742T1 (de) 1997-02-15
SK277996B6 (en) 1995-09-13
CZ233190A3 (en) 1994-02-16
SK277997B6 (en) 1995-09-13
SK260491A3 (en) 1995-09-13
DK0427827T3 (da) 1997-07-07
EP0427827B1 (de) 1997-01-15
JPH04500681A (ja) 1992-02-06
HU212814B (hu) 1998-08-28
PT94011B (pt) 1996-12-31
DD294259A5 (de) 1991-09-26
CZ278981B6 (en) 1994-11-16
DE59010633D1 (de) 1997-03-06
US5547958A (en) 1996-08-20
SK233190A3 (en) 1995-09-13
PT94011A (pt) 1991-01-08
CZ279080B6 (en) 1994-12-15
EP0427827A1 (de) 1991-05-22
DE3915950A1 (de) 1990-11-15
CZ260491A3 (en) 1993-03-17
HUT56363A (en) 1991-08-28
US5212178A (en) 1993-05-18
WO1990013550A1 (de) 1990-11-15
HU904426D0 (en) 1991-07-29

Similar Documents

Publication Publication Date Title
NL194821B (nl) Farmacologisch actieve catecholderivaten en samenstellingen ervan.
IT1192585B (it) Polisaccaride avente attivita' anti-tumorale,procedimento per la sua produzione e sostanza anti-tumorale comprendente detto polisaccaride
DE69024965D1 (de) Dehydrodidemnin b
IT8847556A0 (it) Derivati peptidici, loro preparazione e loro impiego come medicamenti
MX19437A (es) 1,3 oxiatiolanos substituidos con propiedades antivirales y procedimiento para su obtencion
NO900279L (no) Alkylerte polyetyleniminderivater og fremgangsmaate for fremstilling derav samt anvendelse av derivatene.
FI904444A0 (fi) Aktiva limkompositioner.
BR9003915A (pt) Mancal radial com rolamento pre-comprimido
KR880701523A (ko) N,n-디알킬알칸아미드로 되는 조성물 및 그 용도
DE69022840D1 (de) Fördertisch.
ATE6358T1 (de) 2-aminotetralin-verbindungen und pharmazeutische zusammensetzungen mit zentraler alpha1-agonist- wirksamkeit.
SE8400445D0 (sv) Novel pharmaceutical active 1,2,3,4,4a,5,10,10a-octahydrobenzo(g)quinoline derivatives, their production and use
ES2098263T3 (es) 8-alfa-acilamino-ergolinas, su preparacion y su utilizacion como medicamentos.
IT8820388A0 (it) Composizione oftalmologica.
NO890504D0 (no) Vandig, flytende blekepreparat.
IT8920929A0 (it) Nuovi derivati del r( ) 3 chinuclidinolo.
DE69003257D1 (de) Tetralin-Derivate.
ES2056876T3 (es) Compuestos piperidinilicos 1,4-disustituidos.
ES2013025A6 (es) Un metodo para preparar 24r-escimnol.
ES2072869T3 (es) Uso de derivados de la 1,4-dihidropiridina en el tratamiento del alcoholismo.
DE69018955D1 (de) Zuführungseinrichtung für Artikel.
IT8720707A0 (it) Impiego del 2,4-monofurfuriliden-sorbitolo ad uso cosmetico.
SE7713700L (sv) 2-substituerade-1-(omega-aminoalkoxi)bensener
DE69004875D1 (de) Gelbildende Zusammenstellung.
FR2646161B1 (fr) Nouvelles lipopolyamines, leur preparation et leur emploi

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 427827

Country of ref document: ES